Loading clinical trials...
Loading clinical trials...
The study is designed to demonstrate that the combination of AG-013736 with either FOLFIRI or FOLFOX is superior to FOLFIRI or FOLFOX in combination with bevacizumab (Avastin) in delaying tumor progre...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07628998 · Colorectal Neoplasms, Early Detection of Cancer
NCT06342440 · Colorectal Cancer, Colorectal Neoplasms, and more
NCT06662786 · Colorectal Neoplasms
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Antioch, California
Pfizer Investigational Site
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions